PROSCA/BLADDR 2022 | 2022 WHO classification: updates in bladder cancer

Eva Compérat, MD, PhD, Hôpital Tenon, Sorbonne University, Paris, France, provides an overview of the 2022 World Health Organisation (WHO) classification in bladder cancers, including new subtypes, grading of endophytic lesions, updates on molecular profiling of tumors and the role of magnetic resonance imaging (MRI). This interview took place at the Global Congress on Prostate and Bladder Cancer (PROSCA/BLADDR 2022) in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.